Carboplatin AUC10 in metastatic Seminoma (Topic: "Real world evidence (except case studies)") R. Eldebri 1, J. Shamash 1 (1) Barts Health NHS Trust - United Kingdom This study presents a multicentric retrospective analysis aimed at evaluating the use of...
Remote Consultation in Prostate Cancer Clinics: Impact on Carbon Footprint and Patient Satisfaction Khan 1, C. Kent 1, F. Clark 1 (1) University Hospitals Leicester, Leicester - United Kingdom Objective: Healthcare contributes around 4-5% of total UK carbon...
Serum levels of Thymidine Kinase 1 correlate with PSA and tumour shrinkage in metastatic Hormone Sensitive Prostate Cancer (mHSPC) Di Costanzo 1, S. Belli 1, G. Pecoraro 1, F. Migliaccio 1, C. Barraco 1, F. Napolitano 1, A. Servetto 1, R. Bianco 1, L. Formisano 1 (1)...
Transcriptomic Analysis of Patients with Metastatic Hormone-Sensitive Prostate Cancer to Identify Genomic Signatures Involved in the Transition from Androgen-Dependent to Androgen-Independent Phenotype Pecoraro 1, D. Esposito 1, F. Di Costanzo 1, F. Migliaccio 1, C....
Prostate-Specific Membrane Antigen PET-CT findings in biochemical relapse after prostatectomy Artingstall 1, A. Mohamed 1, M. Beresford 1 (1) Royal United Hospital, Bath - United Kingdom Objective: Surveillance for recurrence of prostate cancer after radical...
A case of brain metastasis development despite PSA suppression in a hormone sensitive metastatic prostate cancer patient under apalutamide treatment Stumbo 1, C. Mone 2, G. Tonini 1 (1) Fondazione Policlinico Universitario Campus Bio-Medico of Rome - Italy, (2)...
Evaluating Outcome and Prognostic Factors in Low-Volume Stage IV Hormone-Sensitive Prostate Cancer (mHSPC) M.A. Hassan 1, S. Anpalakhan 2, N. Osman 1, M. Gyi 1, S. Acharige 1, H. Yusof 1, N. Atsumi 1, B. Smalley 1, L. Pedapati 1, R. Nagpal 1, A. Ashraf 3, G.L. Banna...
Southampton experience of prostate specific membrane antigen therapy for metastatic prostate cancer Sundram 1, Z. Saad 1, J. Wilkins 1, C. Longstaff 1 (1) University Hospitals Southampton NHS Foundation Trust - United Kingdom Objective: Prostate specific...
Real-life Analysis of [177Lu]Lu-PSMA-617 on mCRPC Patients cohort treated in France Roubaud 1, F. Somme 2, P. Barthélémy 3, P. Olivier 4, V. Massard 5, A. Giraudet 6, A. Flechon 6, S. Girault 7, S. Abadie Lacourtoisie 7, C. Bailly 8 (1) Department of Medical Oncology,...
Prostate cancer (PC) and homologous recombination repair genes mutations (HRRm): a retrospective, monocentric, observational study aimed at recording histopathological and clinical data and their associations with oncological outcomes. Rossetti 1, M. Di Napoli 1, E....